Ispire FY2026: Revenue Down 25%, Equity Turns Negative, New IT Material Weakness
ISPR sits 43% above its 52-week low of $1.01.
Summary
Ispire's FY2026 10-K reveals a 25% revenue decline, negative stockholders' equity, a new IT material weakness, and a $47M related-party payable deferral — a deteriorating financial picture.
Key Events · Earnings and Guidance · ISPR
-
Revenue Falls 25%, Gross Margin Compresses
FY2026 revenue declined 24.7% to $96.0M from $127.5M, driven by a $17.4M drop in North America and $12.7M in Europe. Gross margin fell to 12.8% from 17.8% on pricing pressure, unfavorable mix shift away from higher-margin cannabis products, and $2.8M in inventory write-downs.
-
Stockholders' Equity Turns Negative
Accumulated deficit reached $81.3M, pushing total stockholders' equity to -$29.2M as of June 30, 2026, compared to +$0.6M a year earlier. Net loss was $33.2M ($0.58/share), an improvement from $39.2M ($0.69/share) but still deeply unprofitable.
-
New IT Material Weakness Disclosed
Management identified a material weakness in IT general controls related to cybersecurity governance, logical access security, and service organization management as of June 30, 2026. Two prior material weaknesses (credit loss/inventory estimates and insufficient accounting personnel) were reported as remediated.
-
Credit Losses Remain Elevated
Allowance for credit losses increased to $26.1M from $18.0M, with $20.7M in credit loss expense and $12.5M in write-offs during FY2026. The company cited persistent long-aged receivables in the cannabis segment despite tighter payment terms.
Analysis · ISPR · Manufacturing
The annual report paints a picture of a business under severe strain. Revenue fell 24.7% to $96.0M, gross margin compressed from 17.8% to 12.8%, and stockholders' equity swung to a negative $29.2M. The allowance for credit losses jumped to $26.1M — nearly 27% of revenue — reflecting serious collection problems in the cannabis segment. Management also disclosed a new material weakness in IT general controls while claiming to have remediated two prior ones. The related-party supplier Shenzhen Yi Jia agreed to defer $47M in payables for 12 months, which provides short-term liquidity relief but underscores dependence on the CEO-controlled supplier. Cash of $19.3M against $44.6M in current liabilities leaves thin runway despite management's assertion of 12-month sufficiency.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.9% of the 1009 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ISPR was trading at $1.44 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $82.7M. The 52-week trading range was $1.01 to $3.87. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.